M. Estée Török

ORCID: 0000-0001-9098-8590
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial Identification and Susceptibility Testing
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotic Resistance in Bacteria
  • Tuberculosis Research and Epidemiology
  • Infectious Diseases and Tuberculosis
  • COVID-19 Clinical Research Studies
  • Streptococcal Infections and Treatments
  • SARS-CoV-2 detection and testing
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Mycobacterium research and diagnosis
  • Bacterial Infections and Vaccines
  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • COVID-19 epidemiological studies
  • Infective Endocarditis Diagnosis and Management
  • Bacterial biofilms and quorum sensing
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • Respiratory viral infections research
  • Clostridium difficile and Clostridium perfringens research
  • Genomics and Phylogenetic Studies
  • Hepatitis B Virus Studies
  • Bacteriophages and microbial interactions
  • Animal Virus Infections Studies

Cambridge University Hospitals NHS Foundation Trust
2015-2024

University of Cambridge
2015-2024

UK Health Security Agency
2022-2023

Imperial College London
1999-2022

Quadram Institute
2022

Public Health England
2013-2021

National Health Service
2011-2021

University of Cologne
2021

University College London
2021

Addenbrooke's Hospital
2010-2020

Merryn Voysey Sue Ann Costa Clemens Shabir A. Madhi Lily Yin Weckx Pedro M. Folegatti and 95 more Parvinder K. Aley Brian Angus Vicky L. Baillie Shaun Barnabas Qasim Bhorat Sagida Bibi Carmen Briner Paola Cicconi Andrea M. Collins Rachel Colin-Jones Clare Cutland Thomas C. Darton Keertan Dheda C.J. Duncan Katherine R. W. Emary Katie Ewer Lee Fairlie Saul N. Faust Shuo Feng Daniela M. Ferreira Adam Finn Anna L. Goodman Catherine Green Christopher Green Paul T. Heath Catherine Hill Helen Hill Ian Hirsch Susanne H. Hodgson Alane Izu Susan Jackson Daniel Jenkin Carina C. D. Joe Simon Kerridge Anthonet Koen Gaurav Kwatra Rajeka Lazarus Alison M. Lawrie Alice Lelliott Vincenzo Libri Patrick Lillie Raburn M. Mallory Ana Verena Almeida Mendes Eveline Pı́polo Milan Angela M. Minassian Alastair McGregor Hazel Morrison Yama F Mujadidi Anusha Nana Peter O’Reilly Sherman D. Padayachee Ana Pittella Emma Plested Katrina M. Pollock Maheshi Ramasamy Sarah Rhead Alexandre Vargas Schwarzbold Nisha Singh Darren Smith Rinn Song Matthew D. Snape Eduardo Sprinz Rebecca Sutherland Richard Tarrant Emma C. Thomson M. Estée Török Mark Toshner David P. J. Turner Johan Vekemans Tonya Villafana Marion Watson Christopher J. Williams Alexander D. Douglas Adrian V. S. Hill Teresa Lambe Sarah C. Gilbert Andrew J. Pollard Marites Aban Fatola Abayomi Kushala W.M. Abeyskera Jeremy Aboagye Matthew Adam Kirsty Adams James P. Adamson Yemi Adelaja Gbadebo Adewetan Syed Adlou Khatija Ahmed Yasmeen Akhalwaya Saajida Akhalwaya Andrew Alcock Aabidah Ali Elizabeth Allen Lauren Allen Thamires C. D. S. C Almeida

SummaryBackgroundA safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of COVID-19 pandemic. We evaluated safety efficacy ChAdOx1 nCoV-19 in a pooled interim analysis four trials.MethodsThis includes data from ongoing blinded, randomised, controlled trials done across UK, Brazil, South Africa. Participants aged 18 years older were randomly assigned (1:1) or (meningococcal group A,...

10.1016/s0140-6736(20)32661-1 article EN cc-by The Lancet 2020-12-08
Merryn Voysey Sue Ann Costa Clemens Shabir A. Madhi Lily Yin Weckx Pedro M. Folegatti and 95 more Parvinder K. Aley Brian Angus Vicky L. Baillie Shaun Barnabas Qasim Bhorat Sagida Bibi Carmen Briner Paola Cicconi Elizabeth Clutterbuck Andrea M. Collins Clare Cutland Thomas C. Darton Keertan Dheda Christina Dold C.J. Duncan Katherine R. W. Emary Katie Ewer Amy Flaxman Lee Fairlie Saul N. Faust Shuo Feng Daniela M. Ferreira Adam Finn Eva Galiza Anna L. Goodman Catherine Green Christopher Green Melanie Greenland Catherine Hill Helen Hill Ian Hirsch Alane Izu Daniel Jenkin Carina C. D. Joe Simon Kerridge Anthonet Koen Gaurav Kwatra Rajeka Lazarus Vincenzo Libri Patrick Lillie Natalie G. Marchevsky Richard P. Marshall Ana Verena Almeida Mendes Eveline Pı́polo Milan Angela M. Minassian Alastair McGregor Yama F Mujadidi Anusha Nana Sherman D. Padayachee Daniel J. Phillips Ana Pittella Emma Plested Katrina M. Pollock Maheshi Ramasamy Adam Ritchie Hannah Robinson Alexandre Vargas Schwarzbold Darren Smith Rinn Song Matthew D. Snape Eduardo Sprinz Rebecca Sutherland Emma C. Thomson M. Estée Török Mark Toshner David P. J. Turner Johan Vekemans Tonya Villafana Thomas B. White Christopher J. Williams Alexander D. Douglas Adrian V. S. Hill Teresa Lambe Sarah C. Gilbert Andrew J. Pollard Marites Aban Kushala W.M. Abeyskera Jeremy Aboagye Matthew Adam Kirsty Adams James P. Adamson Gbadebo Adewatan Syed Adlou Khatija Ahmed Yasmeen Akhalwaya Saajida Akhalwaya Andrew Alcock Aabidah Ali Elizabeth Allen Lauren Allen Felipe B. Alvernaz Fabio Santos Amorim Claudia Sala Andrade Foteini Andritsou Rachel Anslow

The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given an interval 4-12 weeks. planned roll-out in will involve vaccinating people high-risk categories their first dose immediately, delivering second 12 weeks later. Here, we provide both further prespecified pooled analysis trials exploratory analyses impact on immunogenicity efficacy extending...

10.1016/s0140-6736(21)00432-3 article EN cc-by The Lancet 2021-02-21

The emergence of meticillin-resistant Staphylococcus aureus (MRSA) that can persist in the community and replace existing hospital-adapted lineages MRSA means it is necessary to understand transmission dynamics terms hospitals as one entity. We assessed use whole-genome sequencing enhance detection between these settings.We studied a putative outbreak on special care baby unit (SCBU) at National Health Service Foundation Trust Cambridge, UK. used validate expand findings from an...

10.1016/s1473-3099(12)70268-2 article EN cc-by The Lancet Infectious Diseases 2012-11-14
Lucy Rivett Sushmita Sridhar Dominic Sparkes Matthew Routledge Nick K Jones and 95 more Stephen R. Forrest Jamie Young Joana Pereira-Dias William L. Hamilton Mark Ferris M. Estée Török Luke W. Meredith Ravi Gupta Paul Lyons Mark Toshner Ben Warne Josefin Bartholdson Scott Claire Cormie Harmeet K. Gill Iain Kean Mailis Maes Nicola Reynolds Michelle Wantoch Sarah Caddy Laura Caller Theresa Feltwell Grant Hall Myra Hosmillo Charlotte J. Houldcroft Aminu S. Jahun Fahad Khokhar Anna Yakovleva Helen Butcher Daniela Caputo Debra Clapham-Riley Helen Dolling Anita Furlong Barbara Graves Emma Le Gresley Nathalie Kingston Sofia Papadia Hannah Stark Kathleen Stirrups Jennifer Webster Joanna Calder Julie R. Harris Sarah Hewitt Jane Kennet Anne Meadows Rebecca Rastall Criona O Brien Jo Price Cherry Publico Jane Rowlands Valentina Ruffolo Hugo Tordesillas Karen Brookes Laura Canna Isabel Cf da Cruz Katie Dempsey Anne Elmer Naidine Escoffery Heather Jones Carla M. S. Ribeiro Caroline Saunders Angela Wright Rutendo Nyagumbo Anne M. Roberts Ashlea Bucke Simone Hargreaves Danielle Johnson Aileen Narcorda Debbie Read Christian Sparke Lucy Warboys Kirsty Lagadu Lenette Mactavous T Gould Tim Raine Claire Mather Nicola Ramenatte Anne-Laure Vallier Mary Kasanicki Penelope-Jane Eames Chris McNicholas Lisa Thake Neil Bartholomew Nicholas M. Brown Surendra Parmar Hongyi Zhang Ailsa Bowring Geraldine Martell Natalie Quinnell Jo Rae Wright Helen Murphy Benjamin J. Dunmore Ekaterina Legchenko Stefan Gräf Christopher Huang Josh Hodgson

Significant differences exist in the availability of healthcare worker (HCW) SARS-CoV-2 testing between countries, and existing programmes focus on screening symptomatic rather than asymptomatic staff. Over a 3 week period (April 2020), 1032 HCWs were screened for large UK teaching hospital. Symptomatic staff household contacts additionally tested. Real-time RT-PCR was used to detect viral RNA from throat+nose self-swab. 3% group tested positive SARS-CoV-2. 17/30 (57%) truly...

10.7554/elife.58728 article EN cc-by eLife 2020-05-11

The factors that govern the development of tuberculosis disease are incompletely understood. We hypothesized some strains Mycobacterium (M. tuberculosis) more capable causing disseminated than others and may be associated with polymorphisms in host genes responsible for innate immune response to infection. compared bacterial genotype 187 Vietnamese adults tuberculous meningitis (TBM) 237 uncomplicated pulmonary tuberculosis. cases was also 392 cord blood controls from same population....

10.1371/journal.ppat.1000034 article EN cc-by PLoS Pathogens 2008-03-27
Bo Meng Steven A. Kemp Guido Papa Rawlings Datir Isabella A. T. M. Ferreira and 95 more Sara Marelli William T. Harvey Spyros Lytras Ahmed Mohamed Giulia Gallo Nazia Thakur Dami A. Collier Petra Mlčochová Samuel C. Robson Nicholas J. Loman Thomas R. Connor Tanya Golubchik Rocio T. Martinez Nunez Catherine Ludden Sally Corden Ian Johnston David Bonsall Colin P. Smith Ali Raza Awan Giselda Bucca M. Estée Török Kordo Saeed Jacqui Prieto David K. Jackson William L. Hamilton Luke B. Snell Catherine Moore Ewan M. Harrison Sónia Gonçalves Derek Fairley Matthew Loose Joanne Watkins Rich Livett Samuel Moses Roberto Amato Samuel M. Nicholls Matthew Bull Darren Smith Jeff Barrett David M. Aanensen Martin D. Curran Surendra Parmar Dinesh Aggarwal James G. Shepherd Matthew D. Parker Sharon Glaysher Matthew Bashton Anthony P. Underwood Nicole Pacchiarini Katie F. Loveson Kate Templeton Cordelia F. Langford John Sillitoe Thushan I. de Silva Dennis Wang Dominic Kwiatkowski Andrew Rambaut Justin O’Grady Simon Cottrell Matthew T. G. Holden Emma C. Thomson Husam Osman Monique Andersson Anoop Chauhan Mohammed O. Hassan-Ibrahim Mara Lawniczak Alex Alderton Meera Chand Chrystala Constantinidou Meera Unnikrishnan Alistair C. Darby Julian A. Hiscox Steve Paterson Inigo Martincorena Erik Volz Andrew J. Page Oliver G. Pybus Andrew R. Bassett Cristina V. Ariani Michael H. Spencer Chapman Kathy K. Li Rajiv Shah Natasha Jesudason Yusri Taha M. McHugh Rebecca Dewar Aminu S. Jahun Claire McMurray Sarojini Pandey James McKenna Andrew Nelson Gregory R. Young Clare M. McCann Scott Elliott Hannah Lowe

We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase affinity the ACE2 confer antibody escape. In vitro, we show that, although itself is not an evasion mechanism, it increases infectivity associated with enhanced incorporation cleaved into virions. able partially rescue proteins that have acquired Y453F escape...

10.1016/j.celrep.2021.109292 article EN cc-by Cell Reports 2021-06-01

The burden and influence of health-care associated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is unknown. We aimed to examine the use rapid SARS-CoV-2 sequencing combined with detailed epidemiological analysis investigate inform infection control measures.

10.1016/s1473-3099(20)30562-4 article EN cc-by The Lancet Infectious Diseases 2020-07-14

10.1016/s1473-3099(20)30152-3 article EN other-oa The Lancet Infectious Diseases 2020-03-05

Monitoring the spread of SARS-CoV-2 and reconstructing transmission chains has become a major public health focus for many governments around world. The modest mutation rate rapid prevents reconstruction from consensus genome sequences, but within-host genetic diversity could theoretically help identify close contacts. Here we describe patterns in 1181 samples sequenced to high depth duplicate. 95.1% show mutations at detectable allele frequencies. Analyses mutational spectra revealed strong...

10.7554/elife.66857 article EN cc-by eLife 2021-08-13

It is uncertain whether all adults with bacterial meningitis benefit from treatment adjunctive dexamethasone.We conducted a randomized, double-blind, placebo-controlled trial of dexamethasone in 435 patients over the age 14 years who had suspected meningitis. The goal was to determine reduced risk death at 1 month and or disability 6 months.A total 217 were assigned group, 218 placebo group. Bacterial confirmed 300 (69.0%), probable diagnosed 123 (28.3%), an alternative diagnosis made 12...

10.1056/nejmoa070852 article EN New England Journal of Medicine 2007-12-12

<h3>Importance</h3> The latest generation of benchtop DNA sequencing platforms can provide an accurate whole-genome sequence (WGS) for a broad range bacteria in less than day. These could be used to more effectively contain the spread multidrug-resistant pathogens. <h3>Objective</h3> To compare WGS with standard clinical microbiology practice investigation nosocomial outbreaks caused by bacteria, identification genetic determinants antimicrobial resistance, and typing other clinically...

10.1001/jamainternmed.2013.7734 article EN JAMA Internal Medicine 2013-07-24

We used large sequence polymorphisms to determine the genotypes of 397 isolates Mycobacterium tuberculosis from human immunodeficiency virus-uninfected Vietnamese adults with pulmonary (n = 235) or meningeal 162) tuberculosis. compared pretreatment radiographic appearances and presentation, response treatment, outcome tuberculous meningitis between genotypes. Multivariate analysis identified variables independently associated genotype outcome. A higher proportion caused by Euro-American had...

10.1128/jcm.02180-07 article EN Journal of Clinical Microbiology 2008-02-21
Guy Thwaites Matthew Scarborough Alexander J. Szubert Emmanuel Nsutebu Robert Tilley and 95 more Julia Greig Sarah Wyllie Peter Wilson Cressida Auckland Janet Cairns Denise Ward Pankaj Lal Achyut Guleri Neil Jenkins Julian Sutton Martin Wiselka Armando González-Ruiz Clive Graham Paul Chadwick Gavin Barlow N Claire Gordon Bernadette C. Young Sarah Meisner Paul McWhinney Ashley Price David Harvey Deepa Nayar Dakshika Jeyaratnam Tim Planche Jane Minton Fleur Hudson Susan Hopkins John Williams M. Estée Török Martin Llewelyn Jonathan D. Edgeworth Timothy M. Walker Matthew Scarborough Musa Kamfose Ana de Veciana N Claire Gordon Leon Peto Gemma Pill Tiphanie Clarke Laura Watson Bernadette C. Young D. Ll. Griffiths A. N. Vaughn Luke Anson Elian Liu Sanuki Perera Lydia Rylance-Knight Carmen Cantell Ruth Moroney Jonathan D. Edgeworth Guy Thwaites Karen Bisnauthsing Antonio Querol-Rubiera Charlotte Gibbs Amita Patel Carolyn Hemsley Anna L. Goodman Duncan Wyncoll Jason S. Biswas Jennifer M. Fitzpatrick L. Jackson Roberts James Millard N. E. Stone Angela Cape Lisa Hurley Chi Kai Tam Emmanuel Nsutebu Marie-Claire Hoyle Kate Maitland Leona Trainor Helen Reynolds Jennifer Harrison Jim Anson Joseph M. Lewis Jonathan Folb Lynsey Goodwin Nicholas J. Beeching Sarah Dyas Helen Winslow Elizabeth A. Foote Paul C. Roberts Pavithra Natarajan Aleš Chrdle Manuel Fenech Hannah Allsop Robert Tilley Rachel Austin-Hutchison Louise Barrett Karen Brookes Leanne Carwithen Andrew Conbeer Richard Cunningham Charlotte Eglinton Rosie Fok Hannah Gott

BackgroundStaphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, death, by enhancing early S killing, sterilising infected foci blood faster, reducing risks dissemination metastatic infection.MethodsIn this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years)...

10.1016/s0140-6736(17)32456-x article EN cc-by The Lancet 2017-12-14

Tuberculous meningitis (TBM) is the most lethal form of tuberculosis, and new treatments that improve outcomes are required. We randomly assigned adults with TBM to treatment standard antituberculosis alone or in combination ciprofloxacin (750 mg/12 h), levofloxacin (500 gatifloxacin (400 mg/24 h) for first 60 days therapy. Fluoroquinolone concentrations were measured plasma cerebrospinal fluid (CSF) specimens taken at predetermined, times throughout treatment. aimed describe...

10.1128/aac.00064-11 article EN Antimicrobial Agents and Chemotherapy 2011-04-19

Abstract The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered by lack of an effective severe acute respiratory syndrome 2 (SARS-CoV-2) antiviral therapy. Here we report use remdesivir in a patient with COVID-19 and prototypic genetic antibody deficiency X-linked agammaglobulinaemia (XLA). Despite evidence complement activation robust T cell response, developed persistent SARS-CoV-2 pneumonitis, without progressing multi-organ involvement. This unusual clinical...

10.1038/s41467-020-19761-2 article EN cc-by Nature Communications 2020-12-14

Longitudinal genomic and epidemiological surveillance of methicillin-resistant Staphylococcus aureus in the UK reveals extensive transmission hospitals community.

10.1126/scitranslmed.aak9745 article EN Science Translational Medicine 2017-10-25
Coming Soon ...